Overview

A First Time in Human Study in Healthy Male Volunteers for Compound GSK557296.

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
0
Participant gender:
Male
Summary
A study conducted on healthy volunteers to determine the safety, tolerability and affect on the human body by experimental drug GSK557296.
Phase:
Phase 1
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Diketopiperazines
Criteria
Inclusion Criteria:

- Healthy males who are 18 to 45 years of age

- Body mass index between 19 and 30 with a body weight greater than 110 pounds and
deemed healthy by a physician

- Non-smokers

Exclusion Criteria:

- Alcohol consumption averaging more than 7 drinks per week

- Positive for Hepatitis C antibody, Hepatitis B antigen or HIV

- Any use of prescription drugs or non prescription drugs